GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InhaleRx Ltd (ASX:IRX) » Definitions » Additional Paid-In Capital

InhaleRx (ASX:IRX) Additional Paid-In Capital : A$0.00 Mil(As of Jun. 2023)


View and export this data going back to 2017. Start your Free Trial

What is InhaleRx Additional Paid-In Capital?



InhaleRx Additional Paid-In Capital Historical Data

The historical data trend for InhaleRx's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InhaleRx Additional Paid-In Capital Chart

InhaleRx Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial - - - - -

InhaleRx Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

InhaleRx Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

InhaleRx Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of InhaleRx's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


InhaleRx (ASX:IRX) Business Description

Traded in Other Exchanges
N/A
Address
126 Phillip Street, Level 5, Sydney, NSW, AUS, 2000
InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper-proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.

InhaleRx (ASX:IRX) Headlines

No Headlines